We are pleased to announce that Global Biomedica s.r.o., a company specializing in advanced spinal solutions, has successfully obtained CE certification in accordance with the European Medical Device Regulation (EU MDR 2017/745) for its flagship product line – BMD Titanium Implant.
The BMD Titanium Implant family has undergone rigorous assessment to ensure full compliance with the demanding safety, performance, and quality standards set by the MDR. Receiving CE MDR approval confirms that these products meet the highest regulatory benchmarks for clinical safety and efficacy, enhancing trust among healthcare professionals and ensuring patient safety across European markets.
BMD Titanium Implant represents a state-of-the-art range of spinal implants made from medical-grade titanium, designed to support optimal osseointegration, biomechanical stability, and long-term clinical outcomes. The product line leverages cutting-edge surface technologies to promote faster healing and superior fusion.
Achieving CE MDR certification not only reinforces the clinical value of BMD Titanium Implants but also enables Global Biomedica to strengthen its presence across European markets while providing partners and distributors with the assurance of full regulatory compliance.
Congratulations to the entire Global Biomedica team on this important milestone!
About GLOBAL biomedica
GLOBAL biomedica is manufacturer of orthopedic titanium implants, extended by designing and constructing in collaboration with leading experts in this field, using innovative and high quality industrial 3D printing technologies. https://globalbmd.com